211 related articles for article (PubMed ID: 18565317)
21. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families.
Chen LM; Yang KY; Little SE; Cheung MK; Caughey AB
Obstet Gynecol; 2007 Jul; 110(1):18-25. PubMed ID: 17601891
[TBL] [Abstract][Full Text] [Related]
22. [Hereditary nonpolyposis colorectal cancer (Lynch syndrome): a review of the literature and case reports].
Lucci S; Pasta V; Arcieri S; Rivolta R; Candioli S; Manigrasso A; Papetti MT; Cerutti L; Merlino G
G Chir; 2000 Apr; 21(4):177-87. PubMed ID: 10812774
[TBL] [Abstract][Full Text] [Related]
23. The genetics of hereditary colon cancer.
Rustgi AK
Genes Dev; 2007 Oct; 21(20):2525-38. PubMed ID: 17938238
[TBL] [Abstract][Full Text] [Related]
24. Hereditary colorectal cancer syndromes: familial adenomatous polyposis and lynch syndrome.
Al-Sukhni W; Aronson M; Gallinger S
Surg Clin North Am; 2008 Aug; 88(4):819-44, vii. PubMed ID: 18672142
[TBL] [Abstract][Full Text] [Related]
25. Can we identify the high-risk patients to be screened? A genetic approach.
Gammon A; Kohlmann W; Burt R
Digestion; 2007; 76(1):7-19. PubMed ID: 17947814
[TBL] [Abstract][Full Text] [Related]
26. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
Rouprêt M; Yates DR; Comperat E; Cussenot O
Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
[TBL] [Abstract][Full Text] [Related]
27. The management of families affected by hereditary non-polyposis colorectal cancer (HNPCC).
Geary J; Thomas HJ; Mackay J; Dorkins H; Barwell J; Hodgson SV
Fam Cancer; 2007; 6(1):13-9. PubMed ID: 16937234
[TBL] [Abstract][Full Text] [Related]
28. Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening.
Julié C; Trésallet C; Brouquet A; Vallot C; Zimmermann U; Mitry E; Radvanyi F; Rouleau E; Lidereau R; Coulet F; Olschwang S; Frébourg T; Rougier P; Nordlinger B; Laurent-Puig P; Penna C; Boileau C; Franc B; Muti C; Hofmann-Radvanyi H
Am J Gastroenterol; 2008 Nov; 103(11):2825-35; quiz 2836. PubMed ID: 18759827
[TBL] [Abstract][Full Text] [Related]
29. Introduction to molecular and clinical genetics of colorectal cancer syndromes.
Tops CM; Wijnen JT; Hes FJ
Best Pract Res Clin Gastroenterol; 2009; 23(2):127-46. PubMed ID: 19414141
[TBL] [Abstract][Full Text] [Related]
30. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
Green RC; Parfrey PS; Woods MO; Younghusband HB
J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations.
Barrow E; Alduaij W; Robinson L; Shenton A; Clancy T; Lalloo F; Hill J; Evans DG
Clin Genet; 2008 Sep; 74(3):233-42. PubMed ID: 18554281
[TBL] [Abstract][Full Text] [Related]
32. Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk.
Wakefield CE; Meiser B; Homewood J; Ward R; O'Donnell S; Kirk J;
Cancer; 2008 Sep; 113(5):956-65. PubMed ID: 18618513
[TBL] [Abstract][Full Text] [Related]
33. Family and personal history in colorectal cancer patients: what are we missing?
Alberto VO; Harocopos CJ; Patel AA; Clark SK
Colorectal Dis; 2006 Sep; 8(7):612-4. PubMed ID: 16919116
[TBL] [Abstract][Full Text] [Related]
34. [Lynch syndrome and gynaecologic's cancer: follow-up recommendations].
Magri K; Millon G
J Gynecol Obstet Biol Reprod (Paris); 2007 Feb; 36(1):68-71. PubMed ID: 17293255
[TBL] [Abstract][Full Text] [Related]
35. The establishment of an HNPCC register.
Myrhøj T; Bernstein I; Bisgaard ML; Svendsen LB; Sondergaard JO; Mohr J; Dahl S; Bülow S
Anticancer Res; 1994; 14(4B):1647-50. PubMed ID: 7979201
[TBL] [Abstract][Full Text] [Related]
36. Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry.
Vasen HF; Velthuizen ME; Kleibeuker JH; Menko FH; Nagengast FM; Cats A; van der Meulen-de Jong AE; Breuning MH; Roukema AJ; van Leeuwen-Cornelisse I; de Vos Tot Nederveen Cappel WH; Wijnen JT
Fam Cancer; 2016 Jul; 15(3):429-35. PubMed ID: 26973060
[TBL] [Abstract][Full Text] [Related]
37. Role for genetic anticipation in Lynch syndrome.
Nilbert M; Timshel S; Bernstein I; Larsen K
J Clin Oncol; 2009 Jan; 27(3):360-4. PubMed ID: 19075283
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of surveillance programs for families at high and moderate risk of hereditary non-polyposis colorectal cancer.
Olsen KR; Bojesen SE; Gerdes AM; Lindorff-Larsen K; Bernstein IT
Int J Technol Assess Health Care; 2007; 23(1):89-95. PubMed ID: 17234021
[TBL] [Abstract][Full Text] [Related]
39. Risk of multiple colorectal cancer development depends on age and subgroup in individuals with hereditary predisposition.
Lindberg LJ; Wegen-Haitsma W; Ladelund S; Smith-Hansen L; Therkildsen C; Bernstein I; Nilbert M
Fam Cancer; 2019 Apr; 18(2):183-191. PubMed ID: 30302651
[TBL] [Abstract][Full Text] [Related]
40. [Handling of hereditary intestinal cancer].
Møller P; Stormorken A; Apold J
Tidsskr Nor Laegeforen; 2006 Aug; 126(15):1937-9. PubMed ID: 16915319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
